GlassScriptPhysician profile
Marla Davy
NPI 1053784587
$873.40
in general payments reported to CMS, 2019-2025
9 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.62 · 2022: $27.20 · 2023: $419 · 2024: $235 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $247.26 | 2023 | Blastx, Xperience, Surgx |
| Kerecis Limited | $185.50 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $140.63 | 2023-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Smith+Nephew, INC. | $137.05 | 2021-2024 | Grafix Pl, Oasis |
| Convatec INC. | $47.27 | 2024-2025 | |
| Solventum Corporation | $43.81 | 2025 | V.A.C. Veraflo, Activ.A.C., Snap |
| Cashflow Solutions, LLC | $36.41 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Medline Industries LP | $23.74 | 2023 | |
| Integra Lifesciences Corporation | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Davy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.